Skip to Main content Skip to Navigation

Nanomedicinas a base de productos naturales para el tratamiento de la tuberculosis

Abstract : Tuberculosis is a chronic infection located in the lungs during the early stages of this disease. The World Health Organization, annually, registers about 9 million new cases and 1.5 million deaths. In addition, the development of multi-drug resistant strains of Mycobacterium tuberculosis has complicated the global control of tuberculosis. An effective control for this epidemic can be based on two main pharmaceutical strategies. First, the development of novel formulations based on controlled release systems for antitubercular drugs which could be used for establishing more effective therapeutic schemes. A second approach can be focused on development of natural products nanoformulations (e.g. natural extracts) for their application as adjuvants for tuberculosis treatment. In this context, the present research work was focused on the design and development of a nanomedicine based on biodegradable nanoparticles and an antitubercular drug of second line (clofazimine). In addition, organic extracts obtained from Schinus molle were formulated into nanoparticles in order to use them as adjuvants in tuberculosis treatment. The characterization of the nanoformulations established a direct relationship between the physicochemical properties (i.e. particle size, surface charge and release profile) of the active-loaded polymeric nanoparticles (with drug or extract) and the increase of the antitubercular activity in vitro. Particularly, additional in vitro tests showed that nanoencapsulation of S. mole extract decreased their toxicity as compared to a non-encapsulated extract. In conclusion, nanoformulations loaded with clofazimine or extract of S. molle showed to have a high potential to be applied in efficient therapeutic schemes for tuberculosis treatment
Document type :
Complete list of metadata

Cited literature [142 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Thursday, May 3, 2018 - 5:00:08 PM
Last modification on : Friday, June 25, 2021 - 7:14:03 PM
Long-term archiving on: : Monday, September 24, 2018 - 3:04:28 PM


Version validated by the jury (STAR)


  • HAL Id : tel-01784734, version 1



Brenda Armendariz-Barragan. Nanomedicinas a base de productos naturales para el tratamiento de la tuberculosis. Pharmacology. Université de Lyon, 2018. Español. ⟨NNT : 2018LYSE1022⟩. ⟨tel-01784734⟩



Record views


Files downloads